Can optimal primary cytoreduction be predicted in advanced stage epithelial ovarian cancer?
The aim of this study was to determine the ability of preoperative serum CA-125 levels to predict optimal cytoreduction in patients with stage III epithelial ovarian cancer. A retrospective review was made of the records of 40 patients with FIGO stage III ovarian carcinoma who underwent primary cytoreductive surgery. A receiver operating characteristic (ROC) curve was used to determine the most useful CA-125 level in predicting optimal versus suboptimal tumour cytoreduction. Twenty-two (55%) patients were optimally cytoreduced (residual disease
Related Questions
- Can patients with relapsed, previously untreated, stage I epithelial ovarian cancer be successfully treated with salvage therapy?
- Is it justified to classify patients to Stage IIIC epithelial ovarian cancer based on nodal involvement only?
- Can optimal primary cytoreduction be predicted in advanced stage epithelial ovarian cancer?